These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7688463)

  • 1. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
    Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
    Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
    Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
    Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate filament expression in astrocytic neoplasms.
    Cosgrove M; Fitzgibbons PL; Sherrod A; Chandrasoma PT; Martin SE
    Am J Surg Pathol; 1989 Feb; 13(2):141-5. PubMed ID: 2464954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
    Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues.
    Litzky LA; Brooks JJ
    Mod Pathol; 1992 Jan; 5(1):30-4. PubMed ID: 1371872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
    Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
    Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
    Abaza MS; Shaban F; Narayan RK; Atassi MZ
    Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
    Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
    Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells of the lamprey nervous system contain keratin-like proteins.
    Merrick SE; Pleasure SJ; Lurie DI; Pijak DS; Selzer ME; Lee VM
    J Comp Neurol; 1995 May; 355(2):199-210. PubMed ID: 7541809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.